Clinical Trials Logo

Autologous Stem Cell Transplant clinical trials

View clinical trials related to Autologous Stem Cell Transplant.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT01296256 Completed - Clinical trials for Autologous Stem Cell Transplant

Bendamustine, Cytarabine, Etoposide and Melphalan (BeEAM) as Conditioning for Autologous Stem Cell Transplant (ASCT) in Aggressive Non Hodgkin's Lymphoma (NHL).

BeEAM2010-01
Start date: May 2011
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine whether Bendamustine in combination with Etoposide, Cytarabine and Melphalan (BeEAM) are effective as conditioning followed by ASCT in patients with aggressive lymphoma.